Capital Fund Management (CFM)’s Soleno Therapeutics SLNO Stock Holding History

Capital Fund Management (CFM)’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-26,511	Closed	-$888K	–	2361
2026 Q1	$888K	Buy	+26,511	New	+$1.04M	﹤0.01%	1722

Capital Fund Management (CFM)'s SLNO Position: Q2 2026 in Review

Capital Fund Management (CFM) sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 26,511 shares — an estimated $888K sold.

Capital Fund Management (CFM) first reported a position in SLNO in Q1 2026 and held it in 1 quarter. The position peaked at $888K in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Capital Fund Management (CFM) reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Capital Fund Management (CFM) sold 26,511 Soleno Therapeutics shares in Q2 2026, an estimated $888K.
Capital Fund Management (CFM) first reported a position in Soleno Therapeutics in Q1 2026 and held it in 1 quarter.
Capital Fund Management (CFM)'s Soleno Therapeutics position peaked at $888K in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.